CNCure Co., Ltd. is at the forefront of revolutionizing cancer treatment by developing bacteria-based cancer immunotherapeutics and cutting-edge radiopharmaceuticals for molecular imaging and therapy. Our innovative theranostics medical technology is designed to usher in a new paradigm where diagnosis and treatment are seamlessly integrated. As we enter the era of precision medicine, CNCure is committed to leading the K-bio revolution by proactively monitoring health, diagnosing disease progression at an early stage, and delivering the most effective treatments. As part of the JLABS Korea portfolio we are dedicated to advancing the commercialization of our research and development products, bringing next-generation medical technologies to improve global health.